BEAM
Price
$17.25
Change
+$1.02 (+6.28%)
Updated
May 8 closing price
Capitalization
1.63B
95 days until earnings call
PMVP
Price
$0.89
Change
-$0.00 (-0.00%)
Updated
May 8, 04:57 PM (EDT)
Capitalization
46.23M
Earnings call today
Ad is loading...

BEAM vs PMVP

Header iconBEAM vs PMVP Comparison
Open Charts BEAM vs PMVPBanner chart's image
Beam Therapeutics
Price$17.25
Change+$1.02 (+6.28%)
Volume$3.15M
Capitalization1.63B
PMV Pharmaceuticals
Price$0.89
Change-$0.00 (-0.00%)
Volume$100
Capitalization46.23M
BEAM vs PMVP Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PMVP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. PMVP commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a StrongBuy and PMVP is a Hold.

Ad is loading...
COMPARISON
Comparison
May 09, 2025
Stock price -- (BEAM: $17.25 vs. PMVP: $0.88)
Brand notoriety: BEAM and PMVP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 119% vs. PMVP: 173%
Market capitalization -- BEAM: $1.63B vs. PMVP: $46.23M
BEAM [@Biotechnology] is valued at $1.63B. PMVP’s [@Biotechnology] market capitalization is $46.23M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.75B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whilePMVP’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • PMVP’s FA Score: 1 green, 4 red.
According to our system of comparison, BEAM is a better buy in the long-term than PMVP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while PMVP’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 5 bearish.
  • PMVP’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, PMVP is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а -13.01% price change this week, while PMVP (@Biotechnology) price change was -11.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.66%. For the same industry, the average monthly price growth was +15.23%, and the average quarterly price growth was -12.40%.

Reported Earning Dates

BEAM is expected to report earnings on Aug 12, 2025.

PMVP is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (-3.66% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($1.63B) has a higher market cap than PMVP($46.2M). BEAM YTD gains are higher at: -30.444 vs. PMVP (-41.073). PMVP has higher annual earnings (EBITDA): -84.3M vs. BEAM (-383.98M). BEAM has more cash in the bank: 851M vs. PMVP (169M). PMVP has less debt than BEAM: PMVP (1.19M) vs BEAM (161M). BEAM has higher revenues than PMVP: BEAM (63.5M) vs PMVP (0).
BEAMPMVPBEAM / PMVP
Capitalization1.63B46.2M3,532%
EBITDA-383.98M-84.3M455%
Gain YTD-30.444-41.07374%
P/E RatioN/AN/A-
Revenue63.5M0-
Total Cash851M169M504%
Total Debt161M1.19M13,529%
TECHNICAL ANALYSIS
Technical Analysis
BEAMPMVP
RSI
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 18 days ago
76%
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PMVP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TATT31.802.01
+6.75%
TAT Technologies Ltd
EMR109.862.59
+2.41%
Emerson Electric Co
NEXT7.420.09
+1.23%
NextDecade Corp
AGFY22.490.14
+0.63%
Agrify Corporation
AGI27.14-0.10
-0.37%
Alamos Gold

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
+6.32%
CRSP - BEAM
72%
Closely correlated
+5.52%
NTLA - BEAM
66%
Loosely correlated
+13.58%
RXRX - BEAM
63%
Loosely correlated
+4.77%
PRME - BEAM
59%
Loosely correlated
-7.04%
RCKT - BEAM
58%
Loosely correlated
+11.57%
More

PMVP and

Correlation & Price change

A.I.dvisor indicates that over the last year, PMVP has been loosely correlated with RCKT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if PMVP jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PMVP
1D Price
Change %
PMVP100%
+2.28%
RCKT - PMVP
49%
Loosely correlated
+6.18%
XNCR - PMVP
42%
Loosely correlated
-5.61%
CLLS - PMVP
39%
Loosely correlated
-3.48%
RGNX - PMVP
39%
Loosely correlated
-8.59%
COGT - PMVP
38%
Loosely correlated
+0.43%
More